An alloantibody to a high-prevalence MNS antigen in a person with a GP.JL/Mk phenotype
By: J. Ratliff, S. Veneman, J. Ward, C. Lomas-Francis, K. Hue-Roye, R.W Velliquette, L. Sausais, T. Maldonado, J. Miyamoto, Y. Martin, D. Slater and M.E. Reid
Paid access
|Apr 2020Authors
J. Ratliff
Blood Source, Sacramento, CA, USA
S. Veneman
Blood Source, Sacramento, CA, USA
J. Ward
Blood Source, Sacramento, CA, USA
C. Lomas-Francis
Immunochemistry Laboratory, New York Blood Center, New York, NY, USA
K. Hue-Roye
Immunochemistry Laboratory, New York Blood Center, New York, NY, USA
R.W Velliquette
Immunochemistry Laboratory, New York Blood Center, New York, NY, USA
L. Sausais
Immunochemistry Laboratory, New York Blood Center, New York, NY, USA
T. Maldonado
Community Regional Medical Center, Fresno, CA, USA
J. Miyamoto
Community Regional Medical Center, Fresno, CA, USA
Y. Martin
Community Regional Medical Center, Fresno, CA, USA
D. Slater
Community Regional Medical Center, Fresno, CA, USA
M.E. Reid
Immunochemistry Laboratory, New York Blood Center, New York, NY, USA
DOI: https://doi.org/10.21307/immunohematology-2019-332 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 146 - 149
Published on: Apr 1, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 J. Ratliff, S. Veneman, J. Ward, C. Lomas-Francis, K. Hue-Roye, R.W Velliquette, L. Sausais, T. Maldonado, J. Miyamoto, Y. Martin, D. Slater, M.E. Reid, published by American National Red Cross
This work is licensed under the Creative Commons License.